Express Pharma
Home  »  Latest Updates  »  DRL commercialises Vozet tabs in India

DRL commercialises Vozet tabs in India

8

Vozet tabs are indicated for the treatment of allergic Rhinitis and chronic Urticaria

Dr Reddy’s Laboratories (DRL) announced the commercialisation of Vozet tablets in India, indicated for the treatment of allergic Rhinitis and chronic Urticaria.

Vozet tablets contain Levocetirizine 5 mg, and are available in a strip size of 10. The anti-histamine market in India had sales of Rs 1038cr MAT for the most recent twelve months ended in March 2017, according to IMS ORG. Dr Reddy’s will further strengthen its anti-allergy portfolio with the addition of Vozet.

Comments are closed.